These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1337979)

  • 1. [Effect of cefepime on adhesion and phagocytosis of Pseudomonas aeruginosa].
    Conejo MC; Pascual A; Suárez AI; Perea EJ
    Enferm Infecc Microbiol Clin; 1992 Dec; 10(10):587-91. PubMed ID: 1337979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa pre-incubated in ofloxacin.
    Nielsen B; Nielsen H
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):227-32. PubMed ID: 3118637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibiotics on the phagocytosis and killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leukocytes.
    Nishida M; Mine Y; Nonoyama S; Yokota Y
    Chemotherapy; 1976; 22(3-4):203-10. PubMed ID: 178484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.
    Cappelletty DM
    Antimicrob Agents Chemother; 1999 Jan; 43(1):129-33. PubMed ID: 9869577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
    Sultan N; Cirak MY; Erbaş D
    Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilm.
    Takeoka K; Ichimiya T; Yamasaki T; Nasu M
    Chemotherapy; 1998; 44(3):190-7. PubMed ID: 9612609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriological and ultrastructural studies on the effect of subinhibitory beta-lactam concentrations on intraphagocytic killing of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
    Stübner G; Dalhoff A; Voigt WH
    Arzneimittelforschung; 1986 Jun; 36(6):899-904. PubMed ID: 3091042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
    Darveau RP; Cunningham MD
    J Infect Dis; 1990 Oct; 162(4):914-21. PubMed ID: 2119402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.
    Bayer AS; Speert DP; Park S; Tu J; Witt M; Nast CC; Norman DC
    Infect Immun; 1991 Jan; 59(1):302-8. PubMed ID: 1898898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study.
    Su TY; Ye JJ; Yang CC; Huang CT; Chia JH; Lee MH
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):52. PubMed ID: 28738848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxacin-induced alteration of susceptibility of pneumococci and Pseudomonas to phagocytosis by human polymorphonuclear leukocytes.
    Pruul H; Hill N; McDonald PJ
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():19-31. PubMed ID: 6438047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of subminimum inhibitory concentration of ceftriaxone on adherence of Pseudomonas aeruginosa to inert surfaces in an experimental model.
    Onaolapo JA; Salami JO
    Afr J Med Med Sci; 1995 Sep; 24(3):275-81. PubMed ID: 8798964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced killing of Pseudomonas aeruginosa by human polymorphonuclear leukocytes in presence of subinhibitory concentrations of carbenicillin and ticarcillin.
    Petit JC; Daguet GL
    Biomedicine; 1981 Feb; 34(1):29-33. PubMed ID: 6784781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
    Meshulam T; Obedeanu N; Merzbach D; Sobel JD
    Clin Immunol Immunopathol; 1984 Aug; 32(2):151-65. PubMed ID: 6428788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human granulocyte activity against moxalactam-induced filamentous forms of Pseudomonas aeruginosa.
    Hammer MC; Baltch AL; Smith RP; Conroy JV; Bishop M; Michelsen P; Hill L
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1565-70. PubMed ID: 2461161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T; Verbrugh HA; Verhoef J
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
    Cabral DA; Loh BA; Speert DP
    Pediatr Res; 1987 Oct; 22(4):429-31. PubMed ID: 2891100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of Pseudomonas aeruginosa on the phagocytic and killing activity of rabbit polymorphonuclear leukocytes: mechanisms of action of a polymorphonuclear leukocyte inhibitor.
    Nonoyama S; Kojo H; Mine Y; Nishida M; Goto S; Kuwahara S
    Infect Immun; 1979 May; 24(2):399-403. PubMed ID: 110701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.
    Tessier PR; Nicolau DP; Onyeji CO; Nightingale CH
    Chemotherapy; 1999; 45(4):284-95. PubMed ID: 10394012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.